Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1b/2 Study of AZD0120 (Also Known as GC012F), a Chimeric Antigen Receptor T Cell Therapy Targeting CD19 and B Cell Maturation Antigen in Participants With Relapsed or Refractory AL Amyloidosis.
Open-label Phase 1b/2 study with primary objective of this study is to evaluate the safety, tolerability and efficacy of AZD0120 in participants with light cha…
Relapsed AL AmyloidosisRefractory AL AmyloidosisLight Chain Amyloidosis+1 more
Alexion Pharmaceuticals, Inc.NCT07081646
Phase 1
A Phase 1/2 Study of Linvoseltamab in Patients With Relapsed or Refractory Systemic Light Chain Amyloidosis
This study is researching an experimental drug called linvoseltamab ("study drug"). This study is focused on patients who have AL amyloidosis that has returne…
Relapsed/Refractory Systemic Light Chain Amyloidosis
Regeneron PharmaceuticalsNCT06292780